Loading clinical trials...

Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00731016

Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid

We suggest treating the Hutchinson-Gilford Progeria Syndrome by two molecules (zoledronic acid and pravastatin).The therapeutic approach which we propose has for objectives to reduce, to prevent or to...

Lead sponsor: Assistance Publique Hopitaux De Marseille•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 1/2

Umbilical Cord Blood Transfusion in Progeria Syndrome

NCT03871972 · Hutchinson-Gilford Progeria Syndrome

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 8, 2013Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment15

Start dateOct 2008

Last updatedJul 8, 2013

Condition

Hutchinson-Gilford Progeria Syndrome

Locations shown

Laboratoire de Génétique Moléculaire - Hopital de la Timone

Marseille

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 8, 2013Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions